Information Provided By: 
Fly News Breaks for June 25, 2018
LMAT
Jun 25, 2018 | 09:03 EDT
Lake Street analyst Brooks O'Neil initiated LeMaitre Vascular with a Buy rating and $45 price target, contending that its recent biologics-focused acquisitions give it rapidly growing niche products that its sales organization can cross-sell to its installed base of vascular surgeons to expand its "already successful business."
News For LMAT From the Last 2 Days
There are no results for your query LMAT
